| Year |
Citation |
Score |
| 2017 |
Lee AWM, Tung SY, Ng WT, Lee V, Ngan RKC, Choi HCW, Chan LLK, Siu LL, Ng AWY, Leung TW, Yiu HHY, O'Sullivan B, Chappell R. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity. Cancer. PMID 28662313 DOI: 10.1002/Cncr.30850 |
0.331 |
|
| 2016 |
Chappell R, Zhu X. Describing Differences in Survival Curves. Jama Oncology. PMID 27123880 DOI: 10.1001/Jamaoncol.2016.0001 |
0.318 |
|
| 2016 |
Brower JV, Forman JD, Kupelian PA, Petereit DG, Gondi V, Lawton CA, Anger N, Saha S, Chappell R, Ritter MA. Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26755165 DOI: 10.1016/J.Radonc.2015.12.018 |
0.32 |
|
| 2016 |
Lin Y, Chappell R, Gönen M. A systematic selection method for the development of cancer staging systems. Statistical Methods in Medical Research. 25: 1438-51. PMID 23698866 DOI: 10.1177/0962280213486853 |
0.309 |
|
| 2015 |
Lee AW, Ngan RK, Tung SY, Cheng A, Kwong DL, Lu TX, Chan AT, Chan LL, Yiu H, Ng WT, Wong F, Yuen KT, Yau S, Cheung FY, Chan OS, ... Chappell R, et al. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 121: 1328-38. PMID 25529384 DOI: 10.1002/Cncr.29208 |
0.303 |
|
| 2011 |
Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, et al. A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 15-22. PMID 20971520 DOI: 10.1016/J.Radonc.2010.09.023 |
0.303 |
|
| 2010 |
Lawrence JA, Forrest LJ, Turek MM, Miller PE, Mackie TR, Jaradat HA, Vail DM, Dubielzig RR, Chappell R, Mehta MP. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 51: 561-70. PMID 20973393 DOI: 10.1111/J.1740-8261.2010.01695.X |
0.307 |
|
| 2010 |
Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute. 102: 1188-98. PMID 20634482 DOI: 10.1093/Jnci/Djq258 |
0.35 |
|
| 2009 |
Steinberg DM, Fine J, Chappell R. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics (Oxford, England). 10: 94-105. PMID 18556677 DOI: 10.1093/Biostatistics/Kxn018 |
0.488 |
|
| 2008 |
Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 62: 149-57. PMID 17885756 DOI: 10.1007/S00280-007-0585-6 |
0.315 |
|
| 2008 |
Huang B, Chappell R. Three-dose-cohort designs in cancer phase I trials. Statistics in Medicine. 27: 2070-93. PMID 17764082 DOI: 10.1002/Sim.3054 |
0.321 |
|
| 2007 |
Yuan Z, Chappell R, Bailey H. The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach. Biometrics. 63: 173-9. PMID 17447942 DOI: 10.1111/J.1541-0420.2006.00666.X |
0.321 |
|
| 2006 |
Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'sullivan B, Xu SL, Pang ES, Sze WM, Leung TW, Kwan WH, Chan PT, et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 66: 142-51. PMID 16904519 DOI: 10.1016/J.Ijrobp.2006.03.054 |
0.319 |
|
| 2005 |
Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6966-75. PMID 16192584 DOI: 10.1200/Jco.2004.00.7542 |
0.33 |
|
| 2005 |
Jiang H, Fine JP, Chappell R. Semiparametric analysis of survival data with left truncation and dependent right censoring. Biometrics. 61: 567-75. PMID 16011706 DOI: 10.1111/J.1541-0420.2005.00335.X |
0.526 |
|
| 2005 |
JIANG H, FINE JP, KOSOROK MR, CHAPPELL R. Pseudo Self-Consistent Estimation of a Copula Model with Informative Censoring Scandinavian Journal of Statistics. 32: 1-20. DOI: 10.1111/J.1467-9469.2005.00412.X |
0.519 |
|
| 2004 |
Lee AW, Lau WH, Tung SY, Chua D, Chappell R, Siu L, Lau J, Law SC, Xu L. Prospective randomized study on therapeutic gain achieved by addition of chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma (NPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 5506. PMID 28014202 DOI: 10.1200/Jco.2004.22.14_Suppl.5506 |
0.308 |
|
| 2004 |
Meier P, Karrison T, Chappell R, Xie H. The Price of Kaplan–Meier Journal of the American Statistical Association. 99: 890-896. DOI: 10.1198/016214504000001259 |
0.318 |
|
| 2003 |
Karrison TG, Huo D, Chappell R. A group sequential, response-adaptive design for randomized clinical trials Controlled Clinical Trials. 24: 506-522. PMID 14500050 DOI: 10.1016/S0197-2456(03)00092-8 |
0.306 |
|
| 2003 |
Jiang H, Chappell R, Fine JP. Estimating the distribution of nonterminal event time in the presence of mortality or informative dropout. Controlled Clinical Trials. 24: 135-46. PMID 12689735 DOI: 10.1016/S0197-2456(02)00307-0 |
0.53 |
|
| 2002 |
Pan W, Chappell R. Estimation in the cox proportional hazards model with left-truncated and interval-censored data. Biometrics. 58: 64-70. PMID 11890328 DOI: 10.1111/J.0006-341X.2002.00064.X |
0.339 |
|
| 2002 |
Kosorok MR, Fine JP, Jiang H, Chappell R. Asymptotic theory for the gamma frailty model with dependent censoring Annals of the Institute of Statistical Mathematics. 54: 476-499. DOI: 10.1023/A:1022450708498 |
0.52 |
|
| 2001 |
Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP. Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method International Journal of Radiation Oncology Biology Physics. 51: 426-434. PMID 11567817 DOI: 10.1016/S0360-3016(01)01622-4 |
0.306 |
|
| 2001 |
Cheung YK, Chappell R. Sequential designs for phase I clinical trials with late-onset toxicities. Biometrics. 56: 1177-82. PMID 11129476 DOI: 10.1111/J.0006-341X.2000.01177.X |
0.323 |
|
| 2001 |
Fine JP, Jiang H, Chappell R. On semi-competing risks data Biometrika. 88: 907-919. DOI: 10.1093/Biomet/88.4.907 |
0.525 |
|
| 2000 |
Lee AW, Foo W, Law SC, Peters LJ, Poon YF, Chappell R, Sze WM, Tung SY, Lau WH, Ho JH. Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 46: 865-72. PMID 10705007 DOI: 10.1016/S0360-3016(99)00512-X |
0.341 |
|
| 1999 |
Lee AW, Foo W, Law SC, Poon YF, O SK, Tung SY, Sze WM, Chappell R, Lau WH, Ho JH. Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system. International Journal of Cancer. Journal International Du Cancer. 84: 179-87. PMID 10096252 DOI: 10.1002/(Sici)1097-0215(19990420)84:2<179::Aid-Ijc15>3.0.Co;2-6 |
0.306 |
|
| 1998 |
Lee AW, Foo W, Chappell R, Fowler JF, Sze WM, Poon YF, Law SC, Ng SH, O SK, Tung SY, Lau WH, Ho JH. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 40: 35-42. PMID 9422555 DOI: 10.1016/S0360-3016(97)00580-4 |
0.333 |
|
| 1998 |
Pan W, Chappell R. Estimating survival curves with left-truncated and interval-censored data under monotone hazards. Biometrics. 54: 1053-1060. DOI: 10.2307/2533856 |
0.301 |
|
| 1997 |
Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Radiation Oncology Investigations. 5: 289-299. PMID 9436246 DOI: 10.1002/(Sici)1520-6823(1997)5:6<289::Aid-Roi5>3.0.Co;2-U |
0.314 |
|
| 1996 |
Leborgne F, Fowler JF, Leborgne J, Zubizarreta E, Chappell R. Fractionation in medium dose rate brachytherapy of cancer of the cervix. International Journal of Radiation Oncology Biology Physics. 35: 907-914. PMID 8751399 DOI: 10.1016/0360-3016(96)00184-8 |
0.306 |
|
| 1995 |
Lee AW, Chan DK, Fowler JF, Poon YF, Foo W, Law SC, O SK, Tung SY, Chappell R. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 36: 24-31. PMID 8525022 DOI: 10.1016/0167-8140(95)01579-6 |
0.325 |
|
| 1995 |
Petereit DG, Sarkaria JN, Chappell R, Fowler JF, Hartmann TJ, Kinsella TJ, Stitt JA, Thomadsen BR, Buchler DA. The adverse effect of treatment prolongation in cervical carcinoma International Journal of Radiation Oncology, Biology, Physics. 32: 1301-1307. PMID 7635769 DOI: 10.1016/0360-3016(94)00635-X |
0.313 |
|
| 1995 |
Wang Y, Wahba G, Chappell R, Gu C. Simulation studies of smoothing parameter estimates and bayesian confidence intervals in bernoulli ss anova models Communications in Statistics - Simulation and Computation. 24: 1037-1059. DOI: 10.1080/03610919508813292 |
0.569 |
|
| 1995 |
Chappell R, Nondahl DM, Fowler JF. Modeling Dose and Local Control in Radiotherapy Journal of the American Statistical Association. 90: 829-838. DOI: 10.1080/01621459.1995.10476581 |
0.312 |
|
| 1994 |
Sarkaria JN, Petereit DG, Stitt JA, Hartman T, Chappell R, Thomadsen BR, Buchler DA, Fowler JF, Kinsella TJ. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma International Journal of Radiation Oncology, Biology, Physics. 30: 75-82. PMID 8083131 DOI: 10.1016/0360-3016(94)90521-5 |
0.321 |
|
| 1994 |
Mehta MP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, Miles J, Turski P, Kubsad S, Mackie T, Kinsella T. Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage International Journal of Radiation Oncology Biology Physics. 30: 541-549. PMID 7928484 DOI: 10.1016/0360-3016(92)90939-F |
0.327 |
|
| 1988 |
Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5− to 21-Year Follow-up and Analysis of 250 Patients with Rectal Adenocarcinoma Annals of Surgery. 208: 379-389. PMID 3421761 DOI: 10.1097/00000658-198809000-00016 |
0.32 |
|
| Show low-probability matches. |